Wednesday, 08 Jul 2020

Bangla Version

Govt to allow testing kits for antibody test

No icon Pharmaceuticals

Health Desk- 29 June, 2020: The government will authorise the use of rapid testing kits for measuring antibodies in patients infected with the coronavirus.

The Directorate General of Drug Administration (DGDA) has finalised a criterion pending permission from the health ministry, Md Salauddin, director of DGDA told media.

The health ministry formed a 14-member committee to examine the necessity of rapid test kits and the panel suggested it be used for research purposes.

On June 24, the DGDA published a notice on its website, saying kits with a minimum 90 percent sensitivity and 95 percent specificity will be approved.

Package of a rapid antibody test kit must mention that "this is not for diagnosis, but to be used only to detect antibodies".

Following a guideline from the advisory committee, the DGDA has decided to allow production and import of rapid antibody testing kits for some specific uses.

Experts have also opined it is now time for antibody and antigen testing.

"We have been recommending the use of antibody and antigen tests for a long time and believe this is a good initiative," Dr Jahidur Rahman, virologist and assistant professor of Shahid Suhrawardy Medical College, told media.

Such tests are not an alternative to PCR tests, but are rather meant to supplement the process and thus reduce burden on the PCR machines.

Meanwhile, the World Health Organization (WHO) has cautioned that there is no evidence showing serological tests can determine whether a person has immunity or is no longer at risk of re-infection.